Cells expressing the pan T-cell marker Thy1, the B-cell marker B220 and the myeloid marker Mac-1 were isolated using the MiniMacs system (Miltenyi Biotec) according to the manufacturer's guidelines.

“The addition of the QS-B220 to TSA's QPL is the single most significant achievement in our Company's history,” stated Implant Sciences' President and CEO, Glenn D. Bolduc. “We're very proud to be ...

The B220 is now undergoing the final independent validation testing for TSA qualification for air cargo screening. "We are pleased to have been informed last week that our B220 system has ...